T1	p 43 64	myocardial infarction
T2	p 227 269	patients on thrombolytic therapy ( TLT ) .
T3	p 291 333	106 males with Q-MI entered the study . 47
T4	p 378 389	30 patients
T5	p 437 439	29
T6	i 6 39	[ Neoton and thrombolytic therapy
T7	i 239 267	thrombolytic therapy ( TLT )
T8	i 343 380	treatment without TLT and neoton , 30
T9	i 390 525	received TLT with streptokinase preparations , 29 patients were given streptokinase preparations and neoton . Left ventricular systolic
T10	i 551 567	echocardiography
T11	i 667 669	MI
T12	i 817 819	MI
T13	i 1019 1025	Neoton
T14	i 1035 1037	MI
T15	i 1057 1060	TLT
T16	o 149 166	systolic function
T17	o 500 534	Left ventricular systolic function
T18	o 604 614	arrhythmia
T19	o 680 744	TLT failed to arrest progression of left ventricular dilation by
T20	o 760 775	hospital stay .
T21	o 847 899	systolic and diastolic volumes of the left ventricle
T22	o 951 972	Antiarrhythmic action
T23	o 1085 1122	left ventricular systolic dysfunction